Table 6 Treatment of each case of pneumonia and rate of adequate treatment according with the isolated microorganism
Staphylococcus aureus | Legionella pneumophila | Haemophilus influenzae | Pseudomonas aeruginosa | Escherichia coli | Klebsiella pneumoniae | Mycoplasma pneumoniae | Enterobacter aerogenes | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C I | C II | C I | C II | C I | C II | C I | C II | C I | C II | C I | C II | C I | C II | C I | C II | |
Amoxicillin-clavulanate | 1 (0) | – | 1 (1) | – | 5 (3) | – | 1 (1) | – | – | – | – | – | – | – | – | – |
Cefotaxime/ceftriaxone | 3 (1) | – | 1 (0) | 2 (2) | – | – | – | – | – | – | – | – | – | – | 1 (1) | – |
Levofloxacin | 1 (0) | – | – | – | – | 1 (0) | 1 (1) | 1 (1) | 2 (1) | – | – | – | – | – | – | – |
Piperacillin-tazobactam | – | 1 (0) | – | – | – | – | – | 1 (1) | – | 1 (0) | – | – | – | – | – | – |
Amoxicillin-clavulanate plus macrolide | – | – | 1 (0) | 1 (1) | – | – | – | – | – | – | – | – | – | – | – | – |
Amoxicillin-clavulanate plus clindamycin | – | – | – | – | – | – | – | – | – | 1 (0) | – | – | – | – | – | 1 (0) |
Amoxicillin-clavulanate plus levofloxacin | – | 1 (0) | – | – | – | – | – | – | – | – | – | 1 (1) | – | – | – | – |
Cefotaxime/ceftriaxone plus macrolide | 9 (2) | 7 (0) | 6 (0) | 5 (2) | 5 (2) | 3 (0) | 4 (2) | 2 (0) | 1 (1) | 2 (0) | 3 (1) | – | 1 (0) | 1 (0) | – | – |
Cefotaxime/ceftriaxone plus aztreonam | – | – | – | – | – | – | 1 (0) | – | – | – | – | – | – | – | – | – |
Cefotaxime/ceftriaxone plus clindamycin | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Cefotaxime/ceftriaxone plus levofloxacin | 1 (1) | 2 (0) | 1 (1) | 5 (0) | – | 6 (0) | – | 2 (0) | 1 (0) | 3 (0) | 1 (1) | 1 (0) | – | 1 (0) | – | 1 (0) |
Cefepime/ceftazidime plus macrolide | – | 1 (0) | 1 (0) | 1 (0) | 3 (0) | 1 (0) | 1 (1) | – | 1 (1) | – | – | – | – | – | – | – |
Cefepime plus amikacin | – | – | – | – | – | – | – | – | 1 (1) | – | – | – | – | – | – | – |
Cefepime plus ciprofloxacin | – | – | 1 (0) | – | 1 (0) | – | – | – | – | – | – | – | – | – | – | – |
Cefepime plus levofloxacin | – | 2 (1) | – | – | – | 2 (0) | – | – | – | – | – | – | – | – | – | – |
Carbapenem/piperacillin-tazobactam plus amikacin | – | – | – | – | – | – | 1 (0) | – | – | – | – | – | – | – | – | – |
Carbapenem/piperacillin-tazobactam plus clindamycin | – | 1 (0) | – | – | 1 (0) | – | – | – | – | – | – | – | – | – | – | – |
Carbapenem/piperacillin-tazobactam plus ciprofloxacin | 1 (0) | – | – | – | – | – | 2 (1) | – | – | – | – | – | 1 (0) | – | – | – |
Carbapenem/piperacillin-tazobactam plus macrolide | – | 1 (0) | 1 (1) | – | – | 1 (1) | – | 4 (1) | – | – | – | – | – | – | 1 (0) | – |
Levofloxacin plus azithromycin | – | – | – | 1 (0) | – | 1 (0) | – | – | – | – | – | – | – | – | – | – |
Levofloxacin plus tobramycin | – | – | – | – | – | – | – | – | 1 (0) | – | – | – | – | – | – | – |
Piperacillin-tazobactam plus levofloxacin | – | – | 2 (0) | – | – | – | – | 1 (0) | – | – | – | 2 (1) | – | – | – | – |
Overall | 16 | 16 | 15 | 15 | 15 | 15 | 11 | 11 | 7 | 7 | 4 | 4 | 2 | 2 | 2 | 2 |
Adequate according with microorganisma | 16 (100) | 16 (100) | 13 (86.7) | 13 (86.7) | 15 (100) | 15 (100) | 5 (45.5) | 6 (54.5) | 7 (100) | 7 (100) | 4 (100) | 4 (100) | 2 (100) | 2 (100) | 2 (100) | 2 (100) |